mTOR signaling in growth control and disease |
| |
Authors: | Laplante Mathieu Sabatini David M |
| |
Affiliation: | 1 Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA 2 Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 3 Koch Center for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, MA 02139, USA |
| |
Abstract: | The mechanistic target of rapamycin (mTOR) signaling pathway senses and integrates a variety of environmental cues to regulate organismal growth and homeostasis. The pathway regulates many major cellular processes and is implicated in an increasing number of pathological conditions, including cancer, obesity, type 2 diabetes, and neurodegeneration. Here, we review recent advances in our understanding of the mTOR pathway and its role in health, disease, and aging. We further discuss pharmacological approaches to treat human pathologies linked to mTOR deregulation. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|